肝硬化门静脉血栓形成的机制与治疗进展

陈东风; 熊吉

doi:10.3969/j.issn.1001-5256.2017.03.010

肝硬化门静脉血栓形成的机制与治疗进展

DOI: 10.3969/j.issn.1001-5256.2017.03.010

陈东风,
熊吉

第三军医大学大坪医院野战外科研究所消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2940
- HTML全文浏览量: 44
- PDF下载量: 680
- 被引次数: 0
出版历程
- 出版日期: 2017-03-20

Advances in mechanisms and treatment of portal vein thrombosis in patients with liver cirrhosis

Department of Gastroenterology, Research Institute of Field Surgery, Daping Hospital, Third Military Medical University

摘要

摘要: 门静脉血栓(PVT)是指门静脉主干及其门静脉系统分支内形成血栓,是肝硬化的重要并发症之一,肝硬化PVT不仅能加重门静脉高压,增加出血的风险,也可脱落逆行造成小肠急性缺血坏死。针对肝硬化患者PVT形成的机制与治疗的最新观点进行了探讨,提出应根据患者的综合情况选择合适的治疗方案。
- 肝硬化 /
- 静脉血栓形成
Abstract: Portal vein thrombosis (PVT) refers to thrombosis in the main portal vein and portal vein branches and is an important complication of liver cirrhosis.PVT can aggravate portal hypertension, increase the risk of bleeding, and lead to acute ischemic necrosis of the small intestine in case of shedding or retrograde movement.This article focuses on the new points of view on the mechanisms and treatment of PVT in cirrhotic patients and points out that treatment regimen should be selected based on patients' overall conditions.
- liver cirrhosis /
- venous thrombosis

HTML全文

参考文献(20)

[1]OKUDA K, OHNISHI K, KIMURA K, et al.Incidence of portal vein thrombosis in liver cirrhosis.An angiographic study in 708 patients[J].Gastroenterology, 1985, 89 (2) :279-286.

[2]OGREN M, BERGQVIST D, BJORCK M, et al.Portal vein thrombosis:prevalence, patient characteristics and lifetime risk:a population study based on 23, 796 consecutive autopsies[J].World J Gastroenterol, 2006, 12 (13) :2115-2119.

[3]AMITRANO L, GUARDASCIONE MA, BRANCACCIO V, et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis[J].J Hepatol, 2004, 40 (5) :736-741.

[4]ZOCCO MA, Di STASIO E, de CRISTOFARO R, et al.Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51 (4) :682-689.

[5]VALLA DC, RAUTOU PE.The coagulation system in patients with end-stage liver disease[J].Liver Int, 2015, 35 (Suppl 1) :139-144.

[6]NORTHUP PG, CALDWELL SH.Coagulation in liver disease:a guide for the clinician[J].Clin Gastroenterol Hepatol, 2013, 11 (9) :1064-1074.

[7]TRIPODI A, PRIMIGNANI M, CHANTARANGKUL V, et al.Thrombin generation in patients with cirrhosis:the role of platelets[J].Hepatology, 2006, 44 (2) :440-445.

[8]TRIPODI A, MANNUCCI PM.The coagulopathy of chronic liver disease[J].N Engl J Med, 2011, 365 (2) :147-156.

[9]VILLA E, CAMMA C, MARIETTA M, et al.Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis[J].Gastroenterology, 2012, 143 (5) :1253-1260, e1251-e1254.

[10]TRIPODI A, ANSTEE QM, SOGAARD KK, et al.Hypercoagulability in cirrhosis:causes and consequences[J].J Thromb Haemost, 2011, 9 (9) :1713-1723.

[11]LIN JN, CHEN HJ, LIN MC, et al.Risk of venous thromboembolism in patients with splenic injury and splenectomy.A nationwide cohort study[J].Thromb Haemost, 2015, 115 (1) :176-183.

[12]KINJO N, KAWANAKA H, AKAHOSHI T, et al.Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension[J].Brit J Surg, 2010, 97 (6) :910-916.

[13]ROMANO F, CAPROTTI R, CONTI M, et al.Thrombosis of the splenoportal axis after splenectomy[J].Langenbecks Arch Surg, 2006, 391 (5) :483-488.

[14]JIANG GQ, BAI DS, CHEN P, et al.Laparoscopic splenectomy and azygoportal disconnection:a systematic review[J].Jsls, 2015, 19 (4) :e2015.

[15]ZAJA F, BARCELLINI W, CANTONI S, et al.Thrombopietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy.Results of a retrospective, observational GIMEMA study[J].Am J Hematol, 2016, 91 (5) :e293-e295.

[16]BOYER TD, HABIB S.Big spleens and hypersplenism:fix it or forget it?[J].Liver Int, 2015, 35 (5) :1492-1498.

[17]YERDEL MA, GUNSON B, MIRZA D, et al.Portal vein thrombosis in adults undergoing liver transplantation:risk factors, screening, management, and outcome[J].Transplantation, 2000, 69 (9) :1873-1881.

[18]QI X, HAN G, FAN D.Management of portal vein thrombosis in liver cirrhosis[J].Nat Rev Gastroenterol Hepatol, 2014, 11 (7) :435-446.

[19]DELGADO MG, SEIJO S, YEPES I, et al.Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis[J].Clin Gastroenterol Hepatol, 2012, 10 (7) :776-783.

[20]LUCA A, MIRAGLIA R, CARUSO S, et al.Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis[J].Gut, 2011, 60 (6) :846-852.

施引文献

资源附件(0)

访问统计